INFLUENCE OF APO-E POLYMORPHISM ON THE RESPONSE TO SIMVASTATIN TREATMENT IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

被引：0
|
作者：
DEKNIJFF, P
STALENHOEF, AFH
MOL, MJTM
LEUVEN, JAG
SMIT, J
ERKELENS, DW
SCHOUTEN, J
FRANTS, RR
HAVEKES, LM
机构：
[1] TNO, GAUBIUS INST, POB 612, 2300 AP LEIDEN, NETHERLANDS
[2] UNIV HOSP NIJMEGEN, DEPT MED, DIV GEN INTERNAL MED, NIJMEGEN, NETHERLANDS
[3] STATE UNIV UTRECHT HOSP, DEPT ENDOCRINOL, 3511 GV UTRECHT, NETHERLANDS
[4] FREE UNIV AMSTERDAM HOSP, DIV INTERNAL MED, 1081 HV AMSTERDAM, NETHERLANDS
[5] LEIDEN STATE UNIV, DEPT HUMAN GENET, 2312 AV LEIDEN, NETHERLANDS
来源：
ATHEROSCLEROSIS | 1990年 / 83卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：89 / 97
页数：9
相关论文
共 50 条
  • [31] Treatment of patients with homozygous familial hypercholesterolemia with expanded doses of simvastatin
    Raal, FJ
    Pilcher, GJ
    Pieterse, AC
    Stein, EA
    Laskarzewski, P
    Illingworth, DR
    Melino, MR
    Mitchel, YB
    ATHEROSCLEROSIS, 1997, 130 : 119 - 119
  • [32] Treatment of children with heterozygous familial hypercholesterolemia
    Reiner, Zeljko
    Sahebkar, Amirhossein
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 304 : 177 - 178
  • [33] Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
    Raal, Frederick J.
    Kallend, David
    Ray, Kausik K.
    Turner, Traci
    Koenig, Wolfgang
    Wright, R. Scott
    Wijngaard, Peter L. J.
    Curcio, Danielle
    Jaros, Mark J.
    Leiter, Lawrence A.
    Kastelein, John J. P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16): : 1520 - 1530
  • [34] APOLIPOPROTEIN-E POLYMORPHISM AND HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - SEX-SPECIFIC EFFECTS
    FERRIERES, J
    SING, CF
    ROY, M
    DAVIGNON, J
    LUSSIERCACAN, S
    ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (10): : 1553 - 1560
  • [35] Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia
    van der Graaf, Anouk
    Cuffie-Jackson, Cynthia
    Vissers, Maud N.
    Trip, Mieke D.
    Gagne, Claude
    Shi, Genming
    Veltri, Enrico
    Avis, Hans J.
    Kastelein, John J. P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (17) : 1421 - 1429
  • [36] The effects of lovastatin and simvastatin on the diurnal periodicity of plasma mevalonate concentrations in patients with heterozygous familial hypercholesterolemia
    Pappu, AS
    Illingworth, DR
    ATHEROSCLEROSIS, 2002, 165 (01) : 137 - 144
  • [37] PLASMA APO-E IN TANGIER PATIENTS IS MAINLY SIALO-APO-E
    ZANNIS, VI
    BLUM, C
    LEES, R
    BRESLOW, JL
    ARTERIOSCLEROSIS, 1982, 2 (05): : A426 - A426
  • [38] GENDER-RELATED RESPONSE TO FLUVASTATIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    LEITERSDORF, E
    DRUGS, 1994, 47 : 54 - 58
  • [39] PLASMA APO-E IN TANGIER PATIENTS IS MAINLY SIALO-APO-E
    ZANNIS, VI
    BLUM, C
    LEES, R
    BRESLOW, JL
    CIRCULATION, 1982, 66 (04) : 160 - 160
  • [40] Disparities in Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia
    Shustak, Rachel
    Perlstein, Abigail
    Artis, Amanda
    Zavez, Alexis
    Tam, Vicky
    Martino, Giordana
    Brothers, Julie
    CIRCULATION, 2024, 150
12345